Medicinova MNOV
NASDAQ MNOV
$1.41 +0.05 (+3.68%)
As of: Oct 21, 2026 · 3:47 PM EDT

Medicinova (MNOV) EBITDA Margin (2012 - 2025)

Updated

Medicinova (MNOV) posted EBITDA Margin of -2034.97% for Q4 2025, up 702.40 percentage points from the prior quarter.

Analysis

Medicinova (MNOV) EBITDA Margin (2012 - 2025) Analysis & Trends

For FY2025, Medicinova's EBITDA Margin came in at -3237.56%.

  • Annual EBITDA Margin shows a four-year change of -2985.19 percentage points (FY2021 to FY2025).
  • In prior years, Medicinova's EBITDA Margin was -988.00% in FY2023 and -252.38% in FY2021.
  • The Q4 2025 figure stands as the highest quarterly EBITDA Margin since Q3 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Eli Lilly 1,135.76 Bn 1,104.34 Bn 19.71 Bn 53.49%
2 Johnson & Johnson 619.07 Bn 537.60 Bn 17.26 Bn 35.95%
3 AbbVie 503.11 Bn 476.22 Bn 12.70 Bn 49.01%
4 Merck 370.23 Bn 324.61 Bn 12.21 Bn 6.02%
5 Novartis Ag 298.76 Bn 262.75 Bn 11.24 Bn -
6 Astrazeneca 261.14 Bn 234.83 Bn 12.86 Bn 33.11%
7 Amgen 237.54 Bn 192.94 Bn 7.24 Bn 46.01%
8 Gilead Sciences 191.65 Bn 165.84 Bn 6.22 Bn -124.26%
9 Pfizer 170.26 Bn 116.90 Bn 10.94 Bn 39.16%
10 Medicinova 69.40 Mn -53.72 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -2,034.97%
Sep 30, 2025 -2,737.37%
Jun 30, 2025 -2,676.12%
Sep 30, 2023 -114.12%
Sep 30, 2021 -9,586.06%
Mar 31, 2021 -4.88%
Dec 31, 2013 57.28%
Jun 30, 2013 -1,071,782.88%
Mar 31, 2013 -79,457.57%
Dec 31, 2012 -7,021.10%
Sep 30, 2012 -2,790.17%
Jun 30, 2012 -461.66%
Mar 31, 2012 -2,023.20%
API Access

Medicinova EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=MNOV&period=max&api_key=YOUR_API_KEY